What is Bioventus's receipt of deferred consideration?

Bioventus (BVS) reported receipt of deferred consideration of $0 in Q4 2025.

How has Bioventus's receipt of deferred consideration changed year-over-year?

Bioventus's receipt of deferred consideration decreased by 100.0% year-over-year, from $1.13M to $0.

What does receipt of deferred consideration mean?

Measures cash inflows resulting from the collection of deferred payments related to previous business transactions or asset sales. This metric provides insight into the timing of cash realization from past divestitures or contractual arrangements.

Bioventus BVS Receipt of deferred consideration

Receipt of deferred consideration at other companies

MarshMRSH

$12M—

Dolby Laboratories, Inc.DLB

$0—

Hippo HoldingsHIPO

$0—

ConstelliumCSTM

$2M-88.2%

Cardinal Infrastructure Group, Inc. CDNL

$3.77M—

Digital TurbineAPPS

$106K—

Other financials

Income statement

See full

Revenue$132.1M+6.6%

Gross profit$90.8M+9.3%

Operating income$8.4M+72.8%

Net income$3.1M+218%

EPS (diluted)$0.04+200%

Balance sheet

See full

Cash & equivalents$35.8M+57.2%

Total debt$288.4M-21.2%

Total equity$188.9M+27.5%

Total assets$650.5M-5.9%

Cash flow

See full

Operating cash flow$8.9M+146%

CapEx$574.0K-30.5%

Free cash flow$8.4M+141%

Valuation

See full

Market cap$659.19M+51.7%

Enterprise value$911.76M+17.2%

P/E23.1×—

P/S1.1×+0.4×

Profitability

See full

Gross margin68.7%+1.2pp

Operating margin10%—

Net margin4.9%+3.2pp

FCF margin17.5%+13.2pp

Returns & leverage

See full

Return on equity16.9%+10.9pp

Debt / equity1.5×-0.9×

Current ratio1.7×+0.3×

Where this comes from

Reported directly by Bioventus in its filing.

Tagged under the XBRL concept bvs:ProceedsFormDeferredConsideration.

The official record: Bioventus’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bioventus's receipt of deferred consideration.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bioventus's receipt of deferred consideration?: Bioventus (BVS) reported receipt of deferred consideration of $0 in Q4 2025.
How has Bioventus's receipt of deferred consideration changed year-over-year?: Bioventus's receipt of deferred consideration decreased by 100.0% year-over-year, from $1.13M to $0.
What does receipt of deferred consideration mean?: Measures cash inflows resulting from the collection of deferred payments related to previous business transactions or asset sales. This metric provides insight into the timing of cash realization from past divestitures or contractual arrangements.